![](/img/cover-not-exists.png)
PMC55 IMPACT OF THE FDA DRAFT GUIDANCE ON PATIENT REPORTED OUTCOMES (PRO) LABEL CLAIMS FOR APPROVED DRUG PRODUCTS IN THE US: HAS IT MADE A DIFFERENCE?
M Mordin, M Clark, C Siersma, K Copley-Merriman, A GnanasakthyVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73206-x
File:
PDF, 87 KB
english, 2009